Bayer stock heads into the open after a 1.5% Xetra drop
Published on 09/07/2026 at 07:57 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
At the close on September 4, 2026, Bayer stock ended Xetra trading at EUR 48.84, reflecting a decline of roughly 1.5% from the previous session. In that last completed session the shares moved between an intraday low of EUR 48.42 and a high of EUR 49.73, showing a relatively narrow range for the day. According to market data, Bayer lagged the broader DAX index on September 4, 2026, as the benchmark posted a modest gain while Bayer slipped.
September 4, 2026 in numbers
Bayer AG (ISIN DE000BAY0017) closed the September 4, 2026 Xetra session at EUR 48.84, down about 1.5% compared with the prior day, after trading between EUR 48.42 at the low and EUR 49.73 at the high, based on figures cited by ms-aktuell.de and a Xetra overview at finanzen.ch. The same sources indicated that the move left the stock below the level seen around the announcement of Bayer’s multibillion-euro deal with Apollo, and that the closing price stood noticeably under a recent peak near EUR 50 recorded earlier in September 2026. Trading volume on Xetra on September 4, 2026 was reported at several million shares, with intraday liquidity concentrated around the EUR 49 mark, while the DAX index closed that session with a small percent gain, underscoring Bayer’s underperformance versus the home benchmark on that day.
Outlook for today
Today, September 7, 2026, attention around Bayer is centered on ongoing reactions to its large settlement framework with Apollo in the United States, with investors watching for any follow-up communication from the company or regulatory developments that could affect legal risk and financing costs, as highlighted by recent commentary at it-boltwise.de. In addition, broader market sentiment in Europe may be influenced by upcoming economic data releases and central-bank commentary this week, factors that can feed into risk appetite for cyclical names such as Bayer. The company’s next scheduled investor events, including future earnings presentations and conference appearances later in September 2026, are listed in its investor calendar and could provide further updates on portfolio restructuring and debt reduction plans, which remain key themes for the stock.
